Researchers conducted a prospective, randomized study of 249 patients with positive fecal occult blood tests. Patients either received a standard forward-viewing colonoscopy or a full-spectrum colonoscopy with a full-spectrum endoscope.
What they found:
1. Full-spectrum endoscopes did not detect a significantly higher amount of adenomas than standard forward-viewing colonoscopy.
2. Full-spectrum endoscopes also had a significantly longer insertion time.
3. Researchers also found no significant difference in polyp/adenoma detection rates by lesion size or colonic section.
Researchers concluded, “[Full-spectrum endoscopes] did not detect significantly more colorectal neoplasia than forward viewing colonoscopy in a medium-risk colorectal cancer screening population with positive fecal occult blood test.”
More articles on gastroenterology:
Georgia widens scope of CON bill — 5 insights
Gastro Health acquiring Gastroenterology Specialists, continuing Florida expansion efforts — 4 insights
New Jersey appellate court rules on PIP procedures
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.